ANG Lifesciences India Ltd Results Summary

ANG Lifesciences India Ltd’s revenue fell -49.28% since last year same period to ₹48.67Cr in the Q4 2022-2023. On a quarterly growth basis, ANG Lifesciences India Ltd has generated 3.2% jump in its revenue since last 3-months.

ANG Lifesciences India Ltd’s net profit fell -187.81% since last year same period to ₹-4.61Cr in the Q4 2022-2023. On a quarterly growth basis, ANG Lifesciences India Ltd has generated -158.99% fall in its net profits since last 3-months.

ANG Lifesciences India Ltd’s net profit margin fell -273.11% since last year same period to -9.47% in the Q4 2022-2023. On a quarterly growth basis, ANG Lifesciences India Ltd has generated -150.95% fall in its net profit margins since last 3-months.

ANG Lifesciences India Ltd’s earning per share (EPS) fell -98.68% since last year same period to 0.4 in the Q4 2022-2023. This indicates that the ANG Lifesciences India Ltd has generated -98.68% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. ANG Lifesciences India Ltd’s return on equity (ROE) stands at 63.62.